Intratumoral dendritic cells in the anti-tumor immune response

Cellular and Molecular Immunology

Volumn 12, Issue 4, 2015, Pages 387-390

  Liu, Yang ^a   Cao, Xuetao ^a,b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; FC RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL POPULATION; COLORECTAL CANCER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFICACY; DRUG RESPONSE; GENE EXPRESSION PROFILING; HEAD AND NECK CANCER; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LUNG ADENOCARCINOMA; LYMPHOCYTE PROLIFERATION; MACROPHAGE; METASTASIS; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE; TH1 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASMS; PATHOLOGY;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

EID: 84936092900     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.130     Document Type: Short Survey

References (18)

1. Rook AH, Raphael BA. Progress in immunotherapy of cancer. N Engl J Med 2012; 367: 1168
2. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501: 346-354
3. Ledford H. Cancer treatment: The killer within. Nature 2014; 508: 24-26
4. Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 2014; 26: 638-652
5. Ruffell B, Chang-Strachan D, Chan V, Rosenbusch A, Ho C, Pryer N, et al. Macrophage IL-10 blocks CD81 T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cel l 2014; 26: 623-637
6. Marabelle A, Kohrt H, Caux C, Levy R. Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res 2014; 20: 1747-1756
7. Liu Y, Cao X. The origin and function of tumor-Associated macrophages. Cell Mol Immunol 2014; doi: 10.1038/cmi.2014. 83
8. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31: 563-604
9. Liu Q, Zhang C, Sun A, Zheng Y, Wang L, Cao X. Tumor-educated CD11bhighIal ow regulatory dendritic cells suppress T cell response through arginase I. J Immunol 2009; 182: 6207-6216
10. Han Y, Chen Z, Yang Y, Jiang Z, Gu Y, Liu Y, et al. Human CD141 CTLA-41 regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2, 3-dioxygenase production in hepatocellular carcinoma. Hepatology 2014; 59: 567-579
11. Engelhardt JJ, Boldajipour B, Beemiller P, Pandurangi P, Sorensen C, Werb Z, et al. Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. Cancer Cell 2012; 21: 402-417
12. Baker K, Rath T, Flak MB, Arthur JC, Chen Z, Glickman JN, et al. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity 2013; 39: 1095-1107
13. Goc J, Germain C, Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, et al. Dendritic cells in tumor-Associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD81 T cells. Cancer Res 2014; 74: 705-715
14. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31: 51-72
15. Fang H, Ang B, Xu X, Huang X, Wu Y, Sun Y, et al. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells. Cell Mol Immunol 2014; 11: 150-159
16. Xu H, Cao X. Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine. Front Med 2011; 5: 323-332
17. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19: 1423-1437
18. McNutt M. Cancer immunotherapy. Science 2013; 342: 1417